Skip to content

AstralRecalls & reported problems across all models

Resmed Pty Ltd · 3 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

1 open recall names at least one Astral model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
3,253
Deaths reported
26
Injuries reported
31
Recalls
1

We found 3 models of Astral by Resmed Pty Ltd in the FDA's device registry (GUDID). Together they are named in 3,253 adverse event reports in the FDA's MAUDE database, received between Mar 3, 2016 and Sep 29, 2026 — classified as 26 deaths, 31 injuries, 3,196 malfunctions.

The most frequently reported specific device problem is “Protective Measures Problem” (1,090 reports).

1 FDA recall record name at least one of these models by its device identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 34 reportsDec 2023: 22 reportsJan 2024: 12 reportsFeb 2024: 6 reportsMar 2024: 8 reportsApr 2024: 10 reportsMay 2024: 14 reportsJun 2024: 28 reportsJul 2024: 10 reportsAug 2024: 10 reportsSep 2024: 4 reportsOct 2024: 14 reportsNov 2024: 14 reportsDec 2024: 1 reportsJan 2025: 18 reportsFeb 2025: 0 reportsMar 2025: 12 reportsApr 2025: 4 reportsMay 2025: 12 reportsJun 2025: 10 reportsJul 2025: 28 reportsAug 2025: 20 reportsSep 2025: 20 reportsOct 2025: 36 reportsNov 2025: 28 reportsDec 2025: 11 reportsJan 2026: 38 reportsFeb 2026: 26 reportsMar 2026: 14 reportsApr 2026: 40 reportsMay 2026: 18 reportsJun 2026: 21 reportsJul 2026: 0 reportsAug 2026: 3 reportsSep 2026: 4 reportsOct 2026: 0 reports20242025202640
Last 36 months. The most recent month may be incomplete.

Astral recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Jun 25, 2026Open, Classified

    Due to a Supercapacitor electrolyte leakage on Printed Circuit Board Assembly (PCBA) may damage the charger chip, causing fail-safe state and interruption of ventilation therapy.

    Z-2735-2026 · Root cause: Component design/selection · Recall details · FDA record ↗

Most reported Astral problems

Device problems

  • Protective Measures Problem1,090
  • Battery Problem611
  • Failure to Calibrate427
  • Device Displays Incorrect Message354
  • Failure to Charge213
  • Inadequate User Interface180
  • Display or Visual Feedback Problem171
  • Failure of Device to Self-Test166

Patient problems

  • No Clinical Signs, Symptoms or Conditions1,615
  • No Consequences Or Impact To Patient1,239
  • Insufficient Information187
  • No Patient Involvement163
  • Low Oxygen Saturation13
  • Death10
  • Loss of consciousness9
  • Respiratory Distress4

Astral models

3 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent Astral adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Resmed Pty Ltd products

All Resmed Pty Ltd devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page